These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17389163)

  • 1. Antibody responses to pneumococcal polysaccharide vaccine in Taiwanese patients with chronic obstructive pulmonary disease.
    Lai CC; Lee LN; Yu CJ; Hsueh PR; Yang PC; Kuo SH; Luh KT
    J Formos Med Assoc; 2007 Mar; 106(3):196-203. PubMed ID: 17389163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety, tolerability, and immunogenicity of 15-valent pneumococcal conjugate vaccine in healthy adults.
    McFetridge R; Meulen AS; Folkerth SD; Hoekstra JA; Dallas M; Hoover PA; Marchese RD; Zacholski DM; Watson WJ; Stek JE; Hartzel JS; Musey LK
    Vaccine; 2015 Jun; 33(24):2793-9. PubMed ID: 25913828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional immune responses to twelve serotypes after immunization with a 23-valent pneumococcal polysaccharide vaccine in older adults.
    Ahn JG; Kim HW; Choi HJ; Lee JH; Kim KH
    Vaccine; 2015 Sep; 33(38):4770-5. PubMed ID: 26277073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological responses to pneumococcal vaccine in frail older people.
    Ridda I; Macintyre CR; Lindley R; Gao Z; Sullivan JS; Yuan FF; McIntyre PB
    Vaccine; 2009 Mar; 27(10):1628-36. PubMed ID: 19100304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Children with otitis media mount a pneumococcal serotype specific serum IgG and IgA response comparable to healthy controls after pneumococcal conjugate vaccination.
    Menon VJ; Corscadden KJ; Fuery A; Thornton RB; Kirkham LA; Richmond PC; Wiertsema SP
    Vaccine; 2012 Apr; 30(20):3136-44. PubMed ID: 22326775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a Validated Luminex-Based Multiplex Immunoassay for Measuring Immunoglobulin G Antibodies in Serum to Pneumococcal Capsular Polysaccharides.
    Tan CY; Immermann FW; Sebastian S; Pride MW; Pavliakova D; Belanger KA; Watson W; Scott DA; Sidhu M; Jansen KU; Giardina PC
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30089644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenity of the pneumococcal polysaccharide vaccine in COPD patients. The effect of systemic steroids.
    de Roux A; Schmidt N; Rose M; Zielen S; Pletz M; Lode H
    Respir Med; 2004 Dec; 98(12):1187-94. PubMed ID: 15588039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination status and immune response to 13-valent pneumococcal conjugate vaccine in asplenic individuals.
    Nived P; Jørgensen CS; Settergren B
    Vaccine; 2015 Mar; 33(14):1688-94. PubMed ID: 25707692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 22-plex chemiluminescent microarray for pneumococcal antibodies.
    Pickering JW; Hoopes JD; Groll MC; Romero HK; Wall D; Sant H; Astill ME; Hill HR
    Am J Clin Pathol; 2007 Jul; 128(1):23-31. PubMed ID: 17580269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the immunogenicity and safety of polysaccharide and protein-conjugated pneumococcal vaccines among the elderly aged 80 years or older in Japan: an open-labeled randomized study.
    Namkoong H; Funatsu Y; Oishi K; Akeda Y; Hiraoka R; Takeshita K; Asami T; Yagi K; Kimizuka Y; Ishii M; Tasaka S; Suzuki Y; Iwata S; Betsuyaku T; Hasegawa N
    Vaccine; 2015 Jan; 33(2):327-32. PubMed ID: 25448102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained functional serotype-specific antibody after primary and secondary vaccinations with a pneumococcal polysaccharide vaccine in elderly patients with chronic lung disease.
    Ohshima N; Nagai H; Matsui H; Akashi S; Makino T; Akeda Y; Oishi K
    Vaccine; 2014 Feb; 32(10):1181-6. PubMed ID: 24120483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An immunoenzymatic test for IgG antibody levels against 10 serotypes of Streptococcus pneumoniae].
    Leal-Esteban LC; Rojas JL; Jaimes AL; Montoya JD; Montoya NE; Leiva L; Trujillo-Vargas CM
    Biomedica; 2012; 32(1):92-102. PubMed ID: 23235791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response to pneumococcal capsular polysaccharide vaccine in the elderly.
    Sankilampi U; Honkanen PO; Bloigu A; Herva E; Leinonen M
    J Infect Dis; 1996 Feb; 173(2):387-93. PubMed ID: 8568300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of the 23-valent pneumococcal polysaccharide vaccine in Alaska Native chronic alcoholics compared with nonalcoholic Native and non-Native controls.
    McMahon BJ; Parkinson AJ; Bulkow L; Davidson M; Wainwright K; Wolfe P; Schiffman GS
    Am J Med; 1993 Dec; 95(6):589-94. PubMed ID: 8259775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulins and immunogenicity of pneumococcal vaccination in preschool asthma.
    Rose MA; Schubert R; Kujumdshiev S; Kitz R; Zielen S
    Int J Clin Pract; 2006 Nov; 60(11):1425-31. PubMed ID: 17073839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults.
    Musher DM; Manof SB; Liss C; McFetridge RD; Marchese RD; Bushnell B; Alvarez F; Painter C; Blum MD; Silber JL
    J Infect Dis; 2010 Feb; 201(4):516-24. PubMed ID: 20092407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity.
    Romero-Steiner S; Musher DM; Cetron MS; Pais LB; Groover JE; Fiore AE; Plikaytis BD; Carlone GM
    Clin Infect Dis; 1999 Aug; 29(2):281-8. PubMed ID: 10476727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assignment of weight-based immunoglobulin G1 (IgG1) and IgG2 units in antipneumococcal reference serum lot 89-S(F) for pneumococcal polysaccharide serotypes 1, 4, 5, 7F, 9V, and 18C.
    Sikkema DJ; Ziembiec NA; Jones TR; Hildreth SW; Madore DV; Quataert SA
    Clin Diagn Lab Immunol; 2005 Jan; 12(1):218-23. PubMed ID: 15643011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of the American Academy of Pediatrics--recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipients.
    Lin PL; Michaels MG; Green M; Mazariegos GV; Webber SA; Lawrence KS; Iurlano K; Greenberg DP
    Pediatrics; 2005 Jul; 116(1):160-7. PubMed ID: 15995047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine.
    Bryant KA; Block SL; Baker SA; Gruber WC; Scott DA;
    Pediatrics; 2010 May; 125(5):866-75. PubMed ID: 20435707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.